The requirement of both MSK1 and MSK2 in the TPA-induction of the TFF1 gene in human breast cancer cells is clearly shown in studies with the MSK inhibitor H89 and in the MSK1 and MSK2 knockdown cells. Here, RPS6KA5 is linked to breast carcinoma.